Skip to main content

Hepion Pharmaceuticals, Inc.

CTRVP
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001583771

In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesHEPA

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Hepion Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
5 filings
5 insiders, $825.0K in total
Open-market sells
0 filings
Insiders trading
5
Net value
+$825.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Hepion Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Hepion Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
LoPriore Vincent SExecutive Chairman16,250,000IndirectSep 14, 20264
Purcell Michael J.Director3,250,000Sep 10, 20263
Stetz Gary S.Interim CEO3,250,000Aug 21, 20263
LoPriore ChaseVP, Corp. Dev.–Aug 21, 20261
Fisher DaninaDirector–Aug 21, 20261
Liddy James GordonDirector–Aug 21, 20261
Appajosyula SireeshChief Operating Officer3,250,000Aug 21, 20263
Stetz Gary S. IIDirector500,000Aug 21, 20262
Jacob Gary SDirector–Feb 21, 20240
Brancaccio John PChairman–Feb 21, 20240
Block Timothy M.Director–Feb 21, 20240
Lbiati KaoutharDirector–Feb 21, 20240
Wijngaard PeterDirector9,501Nov 28, 20230
Foster Robert TCEO and Director50,470Sep 19, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2026 (view filing)6:30 AM ETSep 311 daysLateLoPriore Vincent SExecutive ChairmanPPurchase+12.5M$0.00$0–22.5M afterDerivative
Aug 12, 2026 (view filing)9:43 PM ETAug 39 daysLateStetz Gary S. IIDirectorPPurchase+500.0K$0.05+$25.0KNew position500.0K after
Aug 12, 2026 (view filing)9:43 PM ETAug 39 daysLateStetz Gary S. IIDirectorPPurchase+500.0K$0.00$0–500.0K afterDerivative
Aug 12, 2026 (view filing)9:41 PM ETAug 39 daysLateStetz Gary S.Interim CEOPPurchase+2.00M$0.05+$100.0K+160.0%3.25M after
Aug 12, 2026 (view filing)9:41 PM ETAug 39 daysLateStetz Gary S.Interim CEOPPurchase+2.00M$0.00$0–2.00M afterDerivative
Aug 12, 2026 (view filing)9:39 PM ETAug 39 daysLatePurcell Michael J.DirectorPPurchase+2.00M$0.05+$100.0K+160.0%3.25M after
Aug 12, 2026 (view filing)9:39 PM ETAug 39 daysLatePurcell Michael J.DirectorPPurchase+2.00M$0.00$0–2.00M afterDerivative
Aug 12, 2026 (view filing)9:36 PM ETAug 39 daysLateAppajosyula SireeshChief Operating OfficerPPurchase+2.00M$0.05+$100.0K+160.0%3.25M after
Aug 12, 2026 (view filing)9:36 PM ETAug 39 daysLateAppajosyula SireeshChief Operating OfficerPPurchase+2.00M$0.00$0–2.00M afterDerivative
Aug 12, 2026 (view filing)9:34 PM ETAug 39 daysLateLoPriore Vincent SExecutive ChairmanPPurchase+10.0M$0.05+$500.0K+160.0%16.3M after2 lots
Aug 12, 2026 (view filing)9:34 PM ETAug 39 daysLateLoPriore Vincent SExecutive ChairmanPPurchase+10.0M$0.00$0–10.0M afterDerivative2 lots
Apr 27, 2026 (view filing)5:33 PM ETApr 216 daysLatePurcell Michael J.DirectorPPurchaseCommon Stock, par value $0.0001 per share+1.25M$0.04+$50.0KNew position1.25M afterDuplicate filing
Apr 27, 2026 (view filing)6:24 AM ETApr 216 daysLateLoPriore Vincent SExecutive ChairmanPPurchaseCommon Stock, par value $0.0001 per share+6.25M$0.04+$250.0KNew position6.25M after2 lots
Apr 27, 2026 (view filing)6:24 AM ETApr 216 daysLateAppajosyula SireeshDirectorPPurchaseCommon Stock, par value $0.0001 per share+1.25M$0.04+$50.0KNew position1.25M afterDuplicate filing
Apr 27, 2026 (view filing)6:24 AM ETApr 216 daysLateStetz Gary S.Interim CEOPPurchaseCommon Stock, par value $0.0001 per share+1.25M$0.04+$50.0KNew position1.25M after
Nov 28, 2023 (view filing)Nov 24-274 daysWijngaard PeterDirectorPPurchase+5.00K$3.07+$15.3K+111.1%9.50K after2 lots
Sep 20, 2023 (view filing)Sep 15-195 daysLateWijngaard PeterDirectorPPurchase+3.00K$5.61+$16.8K+199.9%4.50K after4 lots
Sep 19, 2023 (view filing)Sep 181 dayFoster Robert TCEO and DirectorPPurchase+1.60K$5.60+$8.96K+3.3%50.5K after
Sep 18, 2023 (view filing)Sep 153 daysFoster Robert TCEO,CSO and DirectorPPurchase+1.60K$5.40+$8.64K+3.4%48.9K after